Currently, there are 28.55M common shares owned by the public and among those 18.67M shares have been available to trade.
Insiders at the company have transacted a total of 25 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, accounting for 408,120 shares. Insider sales of the common stock occurred on 10 occasions, with total insider shares sold totaling 31,767 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the script later moved the day high at 0.2530, up 21.21%. The company’s stock has a 5-day price change of 21.27% and 29.66% over the past three months. AFIB shares are trading 18.87% year to date (YTD), with the 12-month market performance down to -84.71% lower. It has a 12-month low price of $0.16 and touched a high of $1.62 over the same period. AFIB has an average intraday trading volume of 1.91 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 19.97%, 21.16%, and -55.68% respectively.
Institutional ownership of Acutus Medical Inc (NASDAQ: AFIB) shares accounts for 5.56% of the company’s 28.55M shares outstanding.
It has a market capitalization of $7.03M and a beta (3y monthly) value of 0.18. The earnings-per-share (ttm) stands at -$1.25. Price movements for the stock have been influenced by the stock’s volatility, which stands at 16.18% over the week and 19.66% over the month.
Analysts forecast that Acutus Medical Inc (AFIB) will achieve an EPS of $0 for the current quarter, $0 for the next quarter and $0 for 2024. The lowest estimate earnings-per-share for the quarter is $0 while analysts give the company a high EPS estimate of $0. Comparatively, EPS for the current quarter was $0.41 a year ago. Earnings per share for the fiscal year are expected to increase by 27.06%, and 34.60% over the next financial year.
Goldman coverage for the Acutus Medical Inc (AFIB) stock in a research note released on October 22, 2021 offered a Neutral rating with a price target of $10. Canaccord Genuity was of a view on July 15, 2021 that the stock is Buy, while William Blair gave the stock Mkt Perform rating on March 19, 2021, issuing a price target of $39- $19. JP Morgan on their part issued Neutral rating on March 19, 2021.
